Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
2.719
+0.019 (0.69%)
Jun 11, 2026, 10:05 AM EDT - Market open
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $25.5 million as of June 11, 2026. Its market cap has decreased by -91.84% in one year.
Market Cap
25.50M
Enterprise Value
522.63K
1-Year Change
-91.84%
Ranking
Category
Stock Price
$2.72
Market Cap Chart
Since April 16, 2025, Tvardi Therapeutics's market cap has decreased from $170.73M to $25.50M, a decrease of -85.06%. That is a compound annual growth rate of -80.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 25.33M | -37.21% |
| Dec 31, 2025 | 40.34M | -76.37% |
| Apr 16, 2025 | 170.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 26.60M |
| BriaCell Therapeutics | 26.37M |
| Serina Therapeutics | 25.92M |
| NeuroSense Therapeutics | 25.85M |
| Lite Strategy | 25.12M |
| Palatin Technologies | 24.91M |
| Quantum BioPharma | 24.53M |
| Pluri | 24.38M |